Cas:197908-31-9 5-methyl-3,4-dihydro-2H-chromen-4-ol manufacturer & supplier

Chemical Name:5-methyl-3,4-dihydro-2H-chromen-4-ol

CAS.NO:197908-31-9

Synonyms:2H-1-Benzopyran-4-ol,3,4-dihydro-5-methyl;5-methyl chroman-4-ol

Molecular Formula:C₁₀H₁₂O₂

Molecular Weight:164.20100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.46000

Exact Mass:164.08400

LogP:1.81090

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2H-1-Benzopyran-4-ol,3,4-dihydro-5-methyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-methyl chroman-4-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-methyl chroman-4-ol Use and application,5-methyl chroman-4-ol technical grade,usp/ep/jp grade.

Related News: Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization. 5-methyl-3,4-dihydro-2H-chromen-4-ol manufacturer Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization. 5-methyl-3,4-dihydro-2H-chromen-4-ol supplier INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 5-methyl-3,4-dihydro-2H-chromen-4-ol vendor INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 5-methyl-3,4-dihydro-2H-chromen-4-ol factory Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant.